|Day Low/High||35.68 / 36.42|
|52 Wk Low/High||33.60 / 55.51|
The drug company declined Sen. Chuck Grassley's request to testify on pricing practices later this month.
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of...
Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C.
Wall Street runs at two speeds as a rally in financials sent the Dow Jones Industrial Average to close at records, while a selloff in tech sank the Nasdaq.
Wall Street remains divided on Thursday as investors try to gauge the types of policies president-elect Donald Trump could enact.
Wall Street ran at two speeds with the Dow Jones Industrial Average setting a record high earlier in the day while the Nasdaq plummeted into the red.
Wall Street runs at two speeds on Thursday with the Dow Jones Industrial Average setting a record high and the S&P 500 and Nasdaq slipping.
Stock futures move higher on Thursday with the Dow Jones Industrial Average set to open at a high.
Impax is Slowly Stealing Market Share from Mylan; Goldman Names New Partners; Twinkie Maker Hostess Brands Preps for Its Next Chapter; and more from The Street.
The pharmaceutical company reported earnings per share of $1.38, missing estimates by 7 cents per share.
Stocks close at session highs on Wednesday as the idea of a Trump presidency settles in. Financial and health care sectors lead the market.
Stocks post solid gains Wednesday after plunging overnight following Donald Trump's surprising victory in the U.S. presidential race.
As we all know, the stock market and the economy abhor uncertainty.
Stocks turn positive Wednesday as investors gauge a Donald Trump presidency on markets. Drug, biotech and financial stocks jump.
Stock futures fall on Wednesday as voters elect Donald Trump as the next U.S. president.
Days after price fixing allegations go public over generic drugs, Taro posts financials showing net sales up thanks to, yes that's right, its U.S. generic drug business.
On Wednesday, November 9, investors will grapple with the aftermath of Tuesday's presidential election, while parsing various earnings reports.
Jim Cramer is keeping an eye on quarterly results from Mylan which are due to be released on Wednesday after the markets close.
Stock futures are lower on Tuesday as voters in the U.S. head to the polls to elect the country's next president.
Potential to be First Submission of a Proposed Biosimilar Trastuzumab in the U.S.
Impax makes a generic version of Adrenaclick, a competitor to Mylan's EpiPen.
Doug Kass shares his thoughts on the bond market's bounciness and stocks suffering election uncertainty.
For the week of November 7, all eyes will be on Tuesday's presidential election.